Bharat Biotech's Covaxin on the brink of WHO approval
- 2 years ago
The World Health Organization has sought clarification from Bharat Biotech on its Covid-19 vaccine — Covaxin — and will meet on Wednesday for a final risk-benefit analysis for its Emergency Use Listing.
The WHO Technical Advisory Group for Emergency Use Listing (EUL) is an independent advisory group that provides recommendations to WHO on whether a Covid-19 vaccine can be listed for emergency use under the EUL procedure, the WHO tweeted.
The WHO Technical Advisory Group for Emergency Use Listing (EUL) is an independent advisory group that provides recommendations to WHO on whether a Covid-19 vaccine can be listed for emergency use under the EUL procedure, the WHO tweeted.